SynthesisJournal of general internal medicine2022

The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.

Jason T Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.